Canada's company discovers the device that detects coronary in the air

The Canadian company is the leader in the energy efficiency and air quality sector through IoT technology, Cloud and Saas. But when the Corleone pandemic hit, the head of this company, Paul Ghezzi, wondered if they could use the power of technology to combat the global health crisis.

Later, the company began working with two microbiology labs in London, including a research lab at Canada's West University, where SARS-CoV-2 samples are stored and developed a device, “BioCloud”.

BioCloud includes a fan that helps to pull air into his room, and then the device begins to analyze the particles of coronary. Situated within an area of some 1,000 square feet [1,000 sq m], such as an office or class, BioCloud has been discovered to be able to tweet the entire inner air many times an hour.

As reported, the Canadian company is planning to start selling the game-changing product in November this year, and the price will be $12,000. The company is now aiming to produce 20,000 units per month, as many interested buyers have shown their interest.